Abstract
The case of a 40 year old female patient of SLE who developed fatal neuroleptic malignant syndrome following administration of serenase (haloperidol) is reported. Relevant literature has been reviewed.
MeSH terms
-
Adult
-
Anti-Dyskinesia Agents / adverse effects*
-
Fatal Outcome
-
Female
-
Haloperidol / adverse effects*
-
Humans
-
Lupus Erythematosus, Systemic / complications*
-
Neuroleptic Malignant Syndrome / diagnosis
-
Neuroleptic Malignant Syndrome / etiology*
Substances
-
Anti-Dyskinesia Agents
-
Haloperidol